Target 6.90 ( 1 to 5 months )Nice Breakout, Good Technical and Fundamental, Target 6.90 , Duration 1 to 5 months.....
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.66EUR
−47.42 MEUR
354.88 KEUR
57.57 M
About Ovid Therapeutics Inc.
Sector
CEO
Jeremy Max Levin
Headquarters
New York
Website
Employees (FY)
40
Founded
2014
FIGI
BBG00GNRNS57
Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.
An aggregate view of professional's ratings.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 1OT is 0.72 EUR — it has increased by 4.35% in the past 24 hours. Watch OVID THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange OVID THERAPEUTICS INC stocks are traded under the ticker 1OT.
1OT stock has risen by 8.27% compared to the previous week, the month change is a 74.29% fall, over the last year OVID THERAPEUTICS INC has showed a 76.16% decrease.
We've gathered analysts' opinions on OVID THERAPEUTICS INC future price: according to them, 1OT price has a max estimate of 4.66 EUR and a min estimate of 1.12 EUR. Watch 1OT chart and read a more detailed OVID THERAPEUTICS INC stock forecast: see what analysts think of OVID THERAPEUTICS INC and suggest that you do with its stocks.
1OT stock is 5.80% volatile and has beta coefficient of 0.50. Track OVID THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is OVID THERAPEUTICS INC there?
Today OVID THERAPEUTICS INC has the market capitalization of 50.98 M, it has increased by 0.34% over the last week.
Yes, you can track OVID THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
OVID THERAPEUTICS INC is going to release the next earnings report on Aug 7, 2024. Keep track of upcoming events with our Earnings Calendar.
1OT earnings for the last quarter are −0.16 EUR per share, whereas the estimation was −0.21 EUR resulting in a 23.93% surprise. The estimated earnings for the next quarter are −0.21 EUR per share. See more details about OVID THERAPEUTICS INC earnings.
OVID THERAPEUTICS INC revenue for the last quarter amounts to 137.16 K EUR, despite the estimated figure of 48.26 K EUR. In the next quarter, revenue is expected to reach 56.89 K EUR.
1OT net income for the last quarter is −10.84 M EUR, while the quarter before that showed −13.88 M EUR of net income which accounts for 21.93% change. Track more OVID THERAPEUTICS INC financial stats to get the full picture.
No, 1OT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 30, 2024, the company has 40.00 employees. See our rating of the largest employees — is OVID THERAPEUTICS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OVID THERAPEUTICS INC EBITDA is −56.04 M EUR, and current EBITDA margin is −14.73 K%. See more stats in OVID THERAPEUTICS INC financial statements.
Like other stocks, 1OT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OVID THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OVID THERAPEUTICS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OVID THERAPEUTICS INC stock shows the strong sell signal. See more of OVID THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.